Can cabozantinib be used for bone metastasis of laryngeal cancer?

Cabozantinib (Cabozantinib) is commonly used to treat many types of cancer, but its use in the treatment of bone metastases from laryngeal cancer has not been extensively studied and proven. Currently, methods such as radiotherapy, chemotherapy, surgery or radioactive isotope therapy are usually used to treat bone metastasis of laryngeal cancer. Regarding the efficacy and safety of cabozantinib in the treatment of bone metastases from laryngeal cancer, more clinical research and trials are needed to determine its applicability and effectiveness in this specific condition. Patients should consult a professional doctor before receiving treatment to develop the best treatment plan based on the specific situation.